Literature DB >> 21322279

[Influence of different blood purification treatment on the serum leptin and neuropeptide Y levels in patients with chronic renal failure].

Jie Song1, Hui Li, Xiao-dong Zhang.   

Abstract

AIM: To study the influence of different blood purification technology on plasma leptin and neuropeptide Y (NPY).
METHODS: 150 patients with chronic renal failure in our hospital were included, which were divided into hemodialysis (HD) group, hemoperfusion (HP) group, and hemofiltration (HF) group. The serum leptin and neuropeptide Y levels were measured by radioimmunoassay (RIA) before and after first treatment, after treatment for 3, 6 month.
RESULTS: Serum leptin and NPY were significantly lower after HDF and HP (P < 0.05), but not after HD in single treatment and for 3, 6 months treatment (P > 0.05). Serum leptin and NPY in group HDF and HP patients in single treatment and for 3, 6 months treatment were significantly greater than those of group HD (P < 0.05). The clearance rate of leptin and NPY in group HDF and HP patients were significantly greater than those of group HD (P < 0.05). There is no correlation between serum leptin and NPY (P > 0.05).
CONCLUSION: Hemodialysis can not lower serum leptin and NPY. But HDF and HP can eliminate serum leptin and NPY preferably, which may improve the patients' nutritional status.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21322279

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

1.  Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.

Authors:  L Lu; Y-C Zou; M Wang; Y-F Huang; D-X Chen; L-B Wei
Journal:  Eur J Clin Nutr       Date:  2015-04-29       Impact factor: 4.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.